Related to Companion Dx Negotiates License to Epigenomics’ Septin9 Blood Biomarker for CRC Test

• 
• Heterodimer Immunoassay Kit
• Singulex
• The Erenna® Interleuken-17A/F (IL-17A/F) heterodimer immunoassay kit is an addition to a suite of TH17 pathway bioassays which also includes IL-17A and IL-17F as well as several others. These biomarkers are members of the IL-17 signaling pathw
• 
• Methylation Analysis
• Zymo Research
• The EZ DNA Methylation-Lightning kit is for complete bisulfite conversion of DNA prior to methylation analysis by PCR, MSP, array, or next-gen sequencing. The ready-to-use liquid-format Lightning conversion reagent is added directly to a DNA sample
• 
• Tumor Marker Control
• Randox Laboratories
• The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
• 
• DNA Reference Standard
• Horizon Discovery
• The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds
• 
• Protein Biomarker Immunoassays
• Olink Bioscience
• Proseek® Multiplex is a generation of multiplexed protein biomarker immunoassays based on the Proximity Extension Assay (PEA) platform. Proseek Multiplex allows biomarker researchers to quantify 92 proteins in one microliter sample against a p
• 
• Epigenetics Conjugates
• Cisbio Bioassays
• The epigenetics toolbox is a selection of conjugates specifically developed for epigenetics studies to help pharmaceutical and biotechnology researchers better understand how these events occur through epigenetic mechanisms and how they relate
• 
• Methylated Gene Targeting
• Cellectis bioresearch
• TALEN™ CpG™ is a service designed to overcome the impact of methylated DNA on TALEN nuclease activity. Users can target any gene at any position in any cell type regardless of methylation status. The service can make gene editing accessible for the